Shortly after the U.S. FDA announced an investigation into the death of a patient who had received Elevidys, a gene therapy ...

The European drug authority recommends refusal of marketing authorization after study shows no benefit over placebo.

The deaths of two teens who received the gene therapy to treat Duchenne muscular dystrophy caused its manufacturer, Sarepta ...